KEEP LIFE FLOWING

Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.
KEEP LIFE FLOWING

Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.
KEEP LIFE FLOWING

Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

About us

Kedrion Biopharma is an international biopharmaceutical company based in Italy that collects and fractionates plasma to produce and distribute worldwide plasma-derived products for the prevention and treatment of rare and debilitating diseases and conditions such as Hemophilia, Primary Immunodeficiencies and Rh sensitization.

In Poland Kedrion Biopharma GmbH (spółka z ograniczoną odpowiedzialnością) Oddział w Polsce is specialized in marketing, sales and distribution of plasma-derivatives.

About us

Kedrion Biopharma is an international company that collects and fractionates blood

plasma to produce and distribute plasma-derived therapeutic products for use in treating

serious diseases, disorders and conditions such as hemophilia and immune system deficiencies.

Kedrion was established in Italy in 2001, but the roots of the companies from which it was

born stretch back several decades in the production of blood and plasma derived products.

A primarily family-owned business, it places a high value not only on the welfare of those

who benefit from its products but also on the people and communities where it operates.

Kedrion around the world

Kedrion Biopharma has a long history of collaboration with the Italian National Health

System, and partners the country in its move toward self-sufficiency in plasma-derived

products. We bring this experience and the dedication to that goal to potential partners

around the world. In recent years Kedrion has expanded its operations – not only into the

United States through Kedrion Biopharma Inc., but into Hungary as well. It now has a

market presence in about 100 countries. In addition, it has acquired collection and

production capacity as well as the rights to significant products for treating hemophilia and

preventing Rh sensitization, a condition which can lead to Hemolytic Disease of the Fetus

and the Newborn (HDFN).

Kedrion looks forward to continued expansion and the wider sharing of its experience,

know-how and technology to foster self-sufficiency of plasma-derived products in

healthcare systems and communities around the world and to bring healthier and less

restricted lives to people suffering from rare disorders.

Vision

Everyone has the right to life, liberty and security of person*

Sometimes, natural, accidental or social causes obstruct the natural right to life, liberty and

personal security. Because of the special nature of its products, Kedrion supports people,

communities and institutions in reducing or removing those obstacles that prevent people

enjoying such rights. Kedrion helps turn the natural rights (life, liberty, security) into the

social right to live in the best possible conditions.

For this reason, it collects and converts, makes active and usable that vital energy that is

generated and regenerated, preserved and carried through blood; so that it can be

transferred from one human being to the next, and anyone can enjoy one’s fundamental

rights.

*Universal Declaration of Human Rights, art. 3.

Our Mission

Kedrion produces and distributes human plasma-derived medicinal products used to treat

and prevent rare and debilitating diseases and disorders.

Kedrion works to maintain

excellent industry standards and aspires to ongoing improvement, in order to retain a

leading position in Italy and to increase its share of the international market. It works to

strengthen its role as the accredited partner of the medical, scientific and institutional

communities.

Kedrion’s ambition is to enhance its worldwide role as a strategic partner of the national

health systems of those countries which aim to become self-sufficient in the availability of

plasma-derived products, also via technology transfer.

Kedrion produces wealth for investors, employees and for the local community,

consistently with its own vision and values: responsibility, transparency, confidence in and

respect for people.

Our commitments

Social Responsibility

To act as responsible global citizens respecting all the communities with whom and for

whom we work.

Transparency

To make accurate and comprehensive information available to all stakeholders.

Quality and Safety

To demonstrate care and respect for our clients, our collaborators and our employees by

continuous emphasis on the quality and safety of all our products and processes.

PRODUCT PORTFOLIO

As a result of its solid and successful experience as partner with the Italian Health System, its significant expansion into international operations and a fundamental commitment to research and development, Kedrion’s line of plasma-derived products is broad and diverse.

With treatments for many rare and debilitating diseases and conditions from hemolytic disease in newborns to immune deficiencies to hemophilia, Kedrion offers a wide and expanding array of treatments and therapies.

Below the list of Kedrion products distributed in Poland (updated March 2022).

RARE DISEASES

CRITICAL CARE & TRANSPLANTATION

KEEP LIFE FLOWING

KEEP LIFE FLOWING

KEEP LIFE FLOWING

About us

PRODUCT PORTFOLIO

Contact us

KEEP LIFE FLOWING

KEEP LIFE FLOWING

KEEP LIFE FLOWING

About us

About us

Kedrion around the world

Vision

Our Mission

Our commitments

Social Responsibility

Transparency

Quality and Safety

PRODUCT PORTFOLIO

RARE DISEASES

HEMATOLOGY / HEMOPHILIA

IMMUNOLOGY / NEUROLOGY

CRITICAL CARE & TRANSPLANTATION

Contact us